| SC 13G/A | 2024-02-09 | Artal International S.C.A. | Aptinyx Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-06-27 | ADAMS STREET PARTNERS LLC | Aptinyx Inc. | 5,395,996 | 8.0% | EDGAR |
| SC 13D/A | 2023-03-16 | Longitude Capital Partners II, LLC | Aptinyx Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-14 | Longitude Capital Partners II, LLC | Aptinyx Inc. | 3,356,746 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-13 | Artal International S.C.A. | Aptinyx Inc. | 6,116,493 | 9.0% | EDGAR |
| SC 13G/A | 2023-01-20 | Kryzanowski John A | Aptinyx Inc. | 6,637,800 | 9.8% | EDGAR |
| SC 13G/A | 2022-06-24 | Kryzanowski John A | Aptinyx Inc. | 1,942,680 | 5.8% | EDGAR |
| SC 13G/A | 2022-06-24 | Kryzanowski John A | Aptinyx Inc. | 4,695,800 | 7.4% | EDGAR |
| SC 13G/A | 2022-06-24 | Kryzanowski John A | Aptinyx Inc. | 5,890,802 | 8.7% | EDGAR |
| SC 13G | 2022-06-24 | Kryzanowski John A | Aptinyx Inc. | 1,781,291 | 5.1% | EDGAR |
| SC 13D/A | 2022-02-11 | New Leaf Ventures III, L.P. | Aptinyx Inc. | 2,921,734 | 4.3% | EDGAR |
| SC 13D/A | 2021-05-04 | Frazier Life Sciences VIII, L.P. | Aptinyx Inc. | 3,190,079 | 4.8% | EDGAR |
| SC 13D/A | 2021-03-26 | Bain Capital Life Sciences Fund, L.P. | Aptinyx Inc. | 8,066,113 | 12.1% | EDGAR |
| SC 13D/A | 2021-02-04 | Frazier Life Sciences VIII, L.P. | Aptinyx Inc. | 3,190,079 | 5.0% | EDGAR |
| SC 13G | 2021-01-29 | Artal International S.C.A. | Aptinyx Inc. | 6,116,493 | 9.7% | EDGAR |
| SC 13D/A | 2020-10-27 | Bain Capital Life Sciences Fund, L.P. | Aptinyx Inc. | 8,066,113 | 13.3% | EDGAR |
| SC 13G/A | 2020-02-14 | Partner Fund Management, L.P. | Aptinyx Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2020-02-13 | New Leaf Ventures III, L.P. | Aptinyx Inc. | 2,921,734 | 6.7% | EDGAR |
| SC 13D/A | 2020-02-12 | Longitude Capital Partners II, LLC | Aptinyx Inc. | 3,356,746 | 7.7% | EDGAR |
| SC 13D | 2020-01-17 | ADAMS STREET PARTNERS LLC | Aptinyx Inc. | - | 11.5% | EDGAR |